Marcelo M Morales Selected Research

Paraquat

11/2010	Recruitment maneuver in experimental acute lung injury: the role of alveolar collapse and edema.
12/2009	Prolonged recruitment manoeuvre improves lung function with less ultrastructural damage in experimental mild acute lung injury.
1/2005	Positive end-expiratory pressure prevents lung mechanical stress caused by recruitment/derecruitment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marcelo M Morales Research Topics

Disease

19	Inflammation (Inflammations) 01/2020 - 01/2011
15	Pneumonia (Pneumonitis) 10/2020 - 01/2010
14	Acute Lung Injury 11/2013 - 01/2005
9	Asthma (Bronchial Asthma) 01/2020 - 02/2013
8	Fibrosis (Cirrhosis) 10/2020 - 01/2011
8	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2019 - 09/2011
7	Lung Injury 03/2023 - 01/2010
7	Edema (Dropsy) 01/2019 - 01/2010
7	Emphysema 11/2018 - 06/2012
4	Sepsis (Septicemia) 03/2023 - 09/2011
4	Silicosis 10/2020 - 01/2014
4	Necrosis 01/2019 - 12/2009
3	Granuloma 10/2020 - 01/2013
3	Lung Diseases (Lung Disease) 10/2020 - 04/2014
3	Cystic Fibrosis (Mucoviscidosis) 11/2018 - 01/2012
3	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2018 - 09/2011
3	Pulmonary Atelectasis 03/2012 - 01/2005
2	Hyperplasia 01/2019 - 01/2011
2	Obesity 01/2019 - 01/2017
2	Pulmonary Arterial Hypertension 11/2018 - 01/2016
2	Body Weight (Weight, Body) 01/2017 - 01/2012
2	Insulin Resistance 01/2017 - 01/2007
2	Disease Progression 01/2016 - 01/2016
2	Cysts 01/2016 - 02/2004
2	Hypertrophy 04/2014 - 01/2011
2	Proteinuria 01/2013 - 03/2005
2	Hyperthyroidism 09/2012 - 01/2007
1	Pneumoconiosis 10/2020
1	Ureteral Obstruction 01/2020
1	Occupational Diseases (Occupational Disease) 01/2018
1	Pulmonary Emphysema 01/2018
1	Respiratory Insufficiency (Respiratory Failure) 01/2018
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 07/2017
1	Infections 01/2017

Drug/Important Bio-Agent (IBA)

11	CollagenIBA 10/2020 - 08/2010
10	Messenger RNA (mRNA)IBA 03/2023 - 03/2009
9	Biomarkers (Surrogate Marker)IBA 01/2019 - 05/2014
8	Therapeutic UsesIBA 01/2020 - 01/2015
8	Interleukin-6 (Interleukin 6)IBA 01/2015 - 12/2009
7	LipopolysaccharidesIBA 01/2018 - 01/2010
6	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2007
6	Pancreatic Elastase (Elastase)IBA 11/2018 - 06/2012
6	Collagen Type III (Type III Collagen)IBA 01/2017 - 06/2009
4	Silicon Dioxide (Silica)FDA LinkGeneric 10/2020 - 01/2014
4	InterleukinsIBA 01/2020 - 06/2009
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018 - 09/2011
3	OvalbuminIBA 01/2017 - 04/2014
3	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 04/2016 - 01/2010
3	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2015 - 01/2010
3	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2015 - 12/2011
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2015 - 08/2010
3	CytokinesIBA 11/2013 - 09/2011
3	Caspase 3 (Caspase-3)IBA 10/2013 - 01/2010
3	ParaquatIBA 11/2010 - 01/2005
2	Interleukin-10 (Interleukin 10)IBA 03/2023 - 08/2010
2	salicylhydroxamic acid (SHAM)IBA 03/2023 - 01/2019
2	Chemotactic FactorsIBA 03/2023 - 01/2019
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 09/2008
2	Circulating Thymic FactorIBA 01/2020 - 04/2014
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2018 - 01/2015
2	AmphiregulinIBA 01/2018 - 12/2016
2	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 01/2007
2	IgA receptor (protein B)IBA 01/2017 - 10/2013
2	Surface-Active Agents (Surfactants)IBA 01/2017 - 10/2013
2	Insulin (Novolin)FDA Link 01/2017 - 01/2007
2	Oxygen (Dioxygen)IBA 04/2016 - 06/2009
2	Chloride Channels (Chloride Channel)IBA 01/2016 - 03/2005
2	CreatinineIBA 05/2015 - 03/2005
2	Receptor for Advanced Glycation End ProductsIBA 01/2015 - 10/2013
2	Benzoates (Benzoate)IBA 09/2012 - 01/2012
2	GasesIBA 08/2010 - 01/2010
1	Omalizumab (Xolair)FDA Link 01/2020
1	coomassie Brilliant BlueIBA 01/2020
1	Purinergic P2X7 ReceptorsIBA 01/2020
1	Interleukin-13IBA 01/2020
1	Technetium (Technetium 99m)IBA 01/2019
1	Eicosapentaenoic AcidIBA 01/2019
1	Tyrosine (L-Tyrosine)FDA Link 11/2018
1	AntioxidantsIBA 01/2018
1	DecorinIBA 01/2018
1	PapainIBA 01/2018
1	Syndecan-1 (Syndecan 1)IBA 01/2018
1	Metalloproteases (Metalloproteinases)IBA 01/2018
1	Matrix Metalloproteinases (MMPs)IBA 01/2018
1	Cell Adhesion MoleculesIBA 01/2018
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 07/2017
1	Low Density Lipoprotein Receptor-Related Protein-2IBA 07/2017
1	intrinsic factor-cobalamin receptorIBA 07/2017
1	TinIBA 01/2017
1	AdiponectinIBA 01/2017
1	Isoflurane FDA LinkGeneric 01/2017

Therapy/Procedure

18	Therapeutics 03/2023 - 01/2010
8	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2020 - 01/2010
7	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 01/2019 - 03/2009
7	Artificial Respiration (Mechanical Ventilation) 01/2019 - 03/2009
5	Punctures 03/2023 - 05/2011
4	Ligation 03/2023 - 05/2011
2	Intravenous Administration 10/2014 - 02/2013
1	Operative Surgical Procedures 03/2023
1	Transplantation 01/2020